Feature selection was performed using the Boruta algorithm, which revealed that both clinical parameters (e.g., age, tumor size, NPI, radiotherapy) and transcriptomic biomarkers (e.g., ATM, HERC2, AKT2, CYP3A43, FOXO3) provided strong prognostic contributions. This evidence concerns the gene AKT2 and neoplasm.